AKT1 and lobular neoplasia: These findings suggest that LCW may modulate the expression of factors such as TNF-α, IL-6, and STAT3, interfere with the PI3K/Akt signaling pathway, and exert anti-inflammatory and immune-modulatory effects, thereby slowing the progression of LN.